Press Releases Avicanna Inc.

Equities

AVCN

CA05368K1003

Delayed Toronto S.E. Other stock markets 11:00:14 2024-05-17 am EDT			5-day change	1st Jan Change
0.36 ^CAD	+2.86%		+12.50%	+2.86%

May. 14	Avicanna Up 4.5% as it Books Record Q1 Revenue, First Adjusted EBITDA Positive Quarter in Company History	MT
May. 14	Avicanna Books Record Q1 Revenue, First Adjusted Ebitda Positive Quarter in Company History	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Avicanna Reports Q1 2024 and First Positive Adjusted EBIDTA Quarter	May. 14	AQ
Avicanna Announces Results of Study in Patients with Epidermolysis Bullosa	May. 13	AQ
Avicanna Announces Closing of Non-brokered Private Placement	Apr. 18	AQ
Avicanna Announces Completion of Topical Gel Observational Real-World Evidence Study	Apr. 10	AQ
Avicanna Reports Full Year 2023 Audited Financial Results	Apr. 02	AQ
Avicanna Announces the Canadian Launch of 10% CBD (THC Free) Proprietary Formulation	Mar. 27	AQ
Avicanna To Hold Full Year 2023 Earnings Conference Call	Mar. 26	AQ
Avicanna Hosts Symposium on Cannabinoid-based Medicine	Feb. 29	AQ
Avicanna Announces New Research Collaboration with a Multi-national European-based Pharmaceutical Company	Feb. 15	AQ
Avicanna Obtains Its First Indication-Specific Drug Registration with Trunerox	Feb. 14	AQ
Avicanna Obtains Its First Indication-Specific Drug Registration with Trunerox™	Feb. 13	AQ
Avicanna Announces Supply and Licensing Agreement with Multinational Pharmaceutical Company	Feb. 05	AQ
Avicanna and Ease Labs Pharma Granted Commercialization Approval for Pharmaceutical Preparation in Brazil	Jan. 30	AQ
Avicanna Reports Q3 2023 Results	Nov. 14	AQ
Avicanna Announces Appointment of Paul Fornazzari to Board of Directors	Nov. 13	AQ
Avicanna To Hold Third Quarter 2023 Earnings Conference Call	Nov. 01	AQ
Avicanna Provides Update on the Successful Launch of MyMedi.ca	23-10-11	AQ
Retirement of Chandra Panchal, PhD from the Board of Directors	23-09-01	AQ
Avicanna Reports Q2 2023 Financial Statement	23-08-15	AQ
Avicanna Announces Closing of Acquisition and Launch of MyMedi.ca	23-08-01	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Avicanna Inc.

Equities

AVCN

CA05368K1003

Press Releases

Filters